The Prognostic Value of Histopathology in Invasive Lung Adenocarcinoma: a Comparative Review of the Main Proposed Grading Systems
Overview
Authors
Affiliations
Introduction: An accurate histological evaluation of invasive lung adenocarcinoma is essential for a correct clinical and pathological definition of the tumour. Different grading systems have been proposed to predict the prognosis of invasive lung adenocarcinoma.
Areas Covered: Invasive non mucinous lung adenocarcinoma is often morphologically heterogeneous, consisting of complex combinations of architectural patterns with different proportions. Several grading systems for non-mucinous lung adenocarcinoma have been proposed, being the main based on architectural differentiation and the predominant growth pattern. Herein we perform a thorough review of the literature using PubMed, Scopus and Web of Science and we highlight the peculiarities and the differences between the main grading systems and compare the data about their prognostic value. In addition, we carried out an evaluation of the proposed grading systems for less common histological variants of lung adenocarcinoma, such as fetal adenocarcinoma and invasive mucinous adenocarcinoma.
Expert Opinion: The current IASLC grading system, based on the combined score of predominant growth pattern plus high-grade histological pattern, shows the stronger prognostic significance than the previous grading systems in invasive non mucinous lung adenocarcinoma.
Liu Y, Lai W, Hung J, Lee Y, Chiang H, Lee J World J Surg Oncol. 2025; 23(1):65.
PMID: 40012069 PMC: 11863481. DOI: 10.1186/s12957-025-03707-3.
Feng J, Shao X, Gao J, Ge X, Sun Y, Shi Y Insights Imaging. 2025; 16(1):4.
PMID: 39747759 PMC: 11695567. DOI: 10.1186/s13244-024-01877-4.
Ruan Y, Cao W, Han J, Yang A, Xu J, Zhang T World J Surg Oncol. 2024; 22(1):302.
PMID: 39543564 PMC: 11566641. DOI: 10.1186/s12957-024-03584-2.
Liang Y, Xie Y, Yu H, Zhu W, Yin C, Dong Z Clin Respir J. 2024; 18(8):e70006.
PMID: 39188060 PMC: 11347615. DOI: 10.1111/crj.70006.
Establishment and verification of novel TNM staging system for lung mucinous adenocarcinoma.
Ge Q, Zheng C, Zhang G, Cong Z, Luo J, Xu Y BMC Cancer. 2024; 24(1):925.
PMID: 39085796 PMC: 11289994. DOI: 10.1186/s12885-024-12714-8.